All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0323-LX301 | Anti-IL6R VHH(X3XH301) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH301 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX675 | Anti-IL6R VHH(X3XH306) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH306 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX676 | Anti-IL6R VHH(X3XH307) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH307 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX677 | Anti-IL6R VHH(X3XH308) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH308 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX678 | Anti-IL6R VHH(X3XH309) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH309 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX679 | Anti-IL6R VHH(X3XH310) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH310 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX680 | Anti-IL6R VHH(X3XH311) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH311 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX681 | Anti-IL6R VHH(X3XH312) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH312 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1039 | Anti-IL6R VHH(X3XH301) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH301 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1040 | Anti-IL6R VHH(X3XH302) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH302 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1041 | Anti-IL6R VHH(X3XH303) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH303 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1042 | Anti-IL6R VHH(X3XH304) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH304 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1043 | Anti-IL6R VHH(X3XH305) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH305 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1044 | Anti-IL6R VHH(X3XH306) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH306 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1045 | Anti-IL6R VHH(X3XH307) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH307 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1046 | Anti-IL6R VHH(X3XH308) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH308 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1047 | Anti-IL6R VHH(X3XH309) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH309 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1048 | Anti-IL6R VHH(X3XH310) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH310 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1049 | Anti-IL6R VHH(X3XH311) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH311 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0723-LX34 | Anti-cIL6R (G10) c(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Canine | G10 | scFv-CD28-41BB-CD4ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0823-LX71 | Anti-hIL6R (AB) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | AB | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION